您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2019, Vol. 57 ›› Issue (6): 1-5.doi: 10.6040/j.issn.1671-7554.0.2019.595

• 子宫内膜异位症的诊断治疗及管理专题 •    

子宫内膜异位症长期管理策略

冷金花,史精华   

  1. 中国医学科学院北京协和医学院, 北京协和医院妇产科, 北京 100730
  • 发布日期:2022-09-27
  • 通讯作者: 冷金花. E-mail:lengjenny@vip.sina.com
  • 基金资助:
    国家重点研发计划(2017YFC1001200)

Long-term management strategy of endometriosis

LENG Jinhua, SHI Jinghua   

  1. Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science &
    Peking Union Medical College, Beijing 100730, China
  • Published:2022-09-27

摘要: 子宫内膜异位症是一种常见的影响女性生殖健康及家庭幸福的慢性病。应建立以临床问题为导向、年龄为分层、多维度的综合长期管理方案,规范手术的时机和方式,强调药物治疗的主导作用,重视随访和教育,旨在提高患者的生活质量。

关键词: 子宫内膜异位症, 长期管理, 策略

Abstract: Endometriosis is a common chronic disease that affects womens reproductive health and family well-being. A comprehensive long-term management scheme based on clinical symptoms, age stratification and multi-dimensional factors should be established. The timing and mode of surgery ought to be standardized, and the leading role of drug therapy should be emphasized. Due attention should be paid to the follow-up and health education so as to improve patients quality of life.

Key words: Endometriosis, Long-term management, Strategy

中图分类号: 

  • R711.71
[1] 冷金花, 史精华. 子宫内膜异位症复发的高危因素及其防治策略[J]. 中华妇产科杂志, 2018, 53(9): 640-643. LENG Jinhua, SHI Jinghua. Risk factors and treatments of endometriosis recurrence[J]. Chinese Journal of Obstetrics and Gynecology, 2018, 53(9): 640-643.
[2] Menakaya U, Infante F, Condous G. Consensus on current management of endometriosis[J]. Human reproduction(Oxford, England), 2013, 28(11): 3162-3163.
[3] 中华医学会妇产科学分会子宫内膜异位症协作组. 子宫内膜异位症的诊治指南[J]. 中华妇产科杂志, 2015,50(3): 161-169. Cooperative Group of Endometriosis, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Guideline for the diagnosis and treatment of endometriosis[J]. Chinese Journal of Obstetrics and Gynecology, 2015, 50(3):161-169.
[4] 中国医师协会妇产科医师分会子宫内膜异位症专业委员会, 中华医学会妇产科学分会子宫内膜异位症协作组. 子宫内膜异位症长期管理中国专家共识[J]. 中华妇产科杂志,2018, 53(12): 836-841. Endometriosis Committee, Chinese Obstetricians and Gynecologists Association; Cooperative Group of Endometriosis, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association.Chinese consensus on the long term management of endometriosis[J]. Chinese Journal of Obstetrics and Gynecology, 2018, 53(12): 836-841.
[5] Bulun SE, Yilmaz BD, Sison C, et al. Endometriosis[J]. Endocrine Reviews, 2019, 17. doi: 10.1210/er.2018-00242.
[6] Patel BG, Lenk EE, Lebovic DI, et al. Pathogenesis of endometriosis: Interaction between Endocrine and inflammatory pathways. Best practice & research[J]. Clinical Obstetrics & Gynaecology, 2018, 50: 50-60. doi: 10.1016/j.bpobgyn.2018.01.006.
[7] Rogers PA, Adamson GD, Al-Jefout M, et al. Research Priorities for Endometriosis: Recommendations From a Global Consortium of Investigators in Endometriosis[J]. Reproductive Sciences, 2016, 24(2): 202.
[8] 冷金花, 戴毅. 子宫内膜异位症治疗新观念[J]. 中华妇产科杂志, 2017, 52(7): 433-435. LENG Jinhua, DAI Yi. Treatment of endometriosis: new ideas[J]. Chinese Journal of Obstetrics and Gynecology, 2017, 52(7): 433-435.
[9] Roman H, Ballester M, Loriau J, et al. Strategies and surgical management of endometriosis: CNGOF-HAS Endometriosis Guidelines[J]. Gynecologie, Obstetrique, Fertilite & Senologie, 2018, 46(3): 326-330.
[10] Broi MGD, Ferriani RA, Navarro PA. Ethiopathogenic mechanisms of endometriosis-related infertility[J]. JBRA Assisted Reproduction, 2019, 15. doi: 10.5935/1518-0557.20190029.
[11] Dunselman GAJ, Vermeulen N, Becker C, et al. ESHRE guideline: management of women with endometriosis[J]. Human Reproduction, 2014, 29(3): 400-412.
[12] Casper RF. Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills[J]. Fertility and Sterility, 2017, 107(3): 533-536.
[13] Geoffron S, Cohen J, Sauvan M, et al. Endometriosis medical treatment: hormonal treatment for the management of pain and endometriotic lesions recurrence. CNGOF-HAS Endometriosis Guidelines[J]. Gynecologie, Obstetrique, Fertilite & Senologie, 2018, 46(3): 231-247.
[14] Vrettakos C, Bajaj T. Levonorgestrel. StatPearls[M]. Treasure Island(FL): StatPearls Publishing LLC, 2019.
[15] Zhao RH, Sun WW, Liu Y, et al. Chinese Medicine in Management of Chronic Disease Endometriosis[J]. Chinese Journal of Integrative Medicine, 2018. doi: 10.1007/s11655-018-2937-3.
[16] Sauvan M, Chabbert-Buffet N, Canis M, et al. Medical treatment for the management of painful endometriosis without infertility: CNGOF-HAS Endometriosis Guidelines[J]. Gynecologie, Obstetrique, Fertilite & Senologie, 2018, 46(3): 267-272.
[17] Bayoglu Tekin Y, Dilbaz B, Altinbas SK, et al. Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue[J]. Fertility and Sterility, 2011, 95(2): 492-496.
[18] Rolla E. Endometriosis: advances and controversies in classification, pathogenesis, diagnosis, and treatment[J]. F1000 Research, 2019, 8. doi: 10.12688/f1000research.14817.1. eCollection 2019.
[19] Chauffour C, Pouly JL, Gremeau AS. Management by assisted reproductive technology in women with endometriosis: CNGOF-HAS Endometriosis Guidelines[J]. Gynecologie, Obstetrique, Fertilite & Senologie, 2018, 46(3): 338-348.
[20] Duffy JMN, Arambage K, Correa FJS, et al. Laparoscopic surgery for endometriosis[J]. Cochrane Database of Systematic Reviews, 2014, 3(4):CD011031. doi: 10.1002/14651858.CD011031.pub2.
[21] Hobo R, Nakagawa K, Usui C, et al. The Endometriosis Fertility Index Is Useful for Predicting the Ability to Conceive without Assisted Reproductive Technology Treatment after Laparoscopic Surgery, Regardless of Endometriosis[J]. Gynecologic and Obstetric Investigation, 2018, 83(5): 493-498.
[22] Pantou A, Simopoulou M. The Role of Laparoscopic investigation in enabling natural conception and avoiding in vitro fertilization overuse for infertile patients of unidentified aetiology and recurrent implantation failure following in vitro fertilization[J]. J Clin Med, 2019, 8(4): 548.
[23] Vercellini P, Vigano P, Buggio L, et al. Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated?[J]. Best Practice & Research, Clinical Obstetrics & Gynaecology, 2018, 51: 151-168.
[24] Sauvan M, Chabbert-Buffet N, Geoffron S, et al. Management of painful endometriosis in adolescents: CNGOF-HAS Endometriosis Guidelines[J]. Gynecologie, Obstetrique, Fertilite & Senologie, 2018, 46(3): 264-266.
[25] Saridogan E. Adolescent endometriosis[J]. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 2017, 209: 46-49.
[26] Staal AH, van der Zanden M, Nap AW. Diagnostic Delay of Endometriosis in the Netherlands[J]. Gynecologic and obstetric investigation, 2016, 81(4): 321-324.
[27] Darwish B, Roman H. Surgical treatment of deep infiltrating rectal endometriosis: in favor of less aggressive surgery[J]. Am J Obstet Gynecol, 2016, 215(2): 195-200.
[28] Hudelist G, Tammaa A, Aas-Eng MK. Outcome of sonography-based minimally invasive surgery for deep infiltrating endometriosis of the ureter and urinary bladder-a retrospective cohort study[J]. 2018, 97(3): 277-284.
[29] Iversen ML, Seyer-Hansen M, Forman A. Does surgery for deep infiltrating bowel endometriosis improve fertility? A systematic review[J]. Acta Obstetricia et Gynecologica Scandinavica, 2017, 96(6): 688-693.
[30] Marie-Scemama L, Even M, De La Joliniere JB, et al. Endometriosis and the menopause: why the question merits our full attention[J]. Hormone Molecular Biology and Clinical Investigation, 2019, 37(2). doi: 10.1515/hmbci-2018-0071.
[31] 何政星, 王姝, 冷金花, 等. 子宫内膜异位症恶变的临床风险分析[J]. 中华妇产科杂志,2018, 53(4): 282-284.
[32] Shi J, Leng J, Cui Q, et al. Follicle loss after laparoscopic treatment of ovarian endometriotic cysts[J]. Int J Gynaecol Obstet, 2011, 115(3): 277-281.
[33] 史精华, 冷金花, 郎景和, 等. 腹腔镜双侧卵巢子宫内膜异位囊肿剔除术对卵巢储备功能及生育的影响及其相关因素分析[J]. 现代妇产科进展, 2013, 22(1): 51-53.
[34] Saridogan E, Becker CM, Feki A, et al. Recommendations for the surgical treatment of endometriosis-part 1: ovarian endometrioma[J]. Gynecological Surgery, 2017, 14(1): 27. doi: 10.1186/s10397-017-1029-x.
[35] Van Niekerk L, Weaver-Pirie B, Matthewson M. Psychological interventions for endometriosis-related symptoms: a systematic review with narrative data synthesis[J]. Archives of Womens Mental Health, 2019. doi: 10.1007/s00737-019-00972-6.
[36] Vannuccini S, Lazzeri L, Orlandini C, et al. Mental health, pain symptoms and systemic comorbidities in women with endometriosis: a cross-sectional study[J]. J Psychosom Obstet Gynaecol, 2018, 39(4): 315-320.
[1] 颜磊,岳彩欣,刘懿淳. 子宫内膜异位症的生育力保护[J]. 山东大学学报 (医学版), 2022, 60(9): 31-34.
[2] 鹿群,赵璐璐. 子宫内膜癌、子宫内膜非典型增生保留生育功能后助孕策略[J]. 山东大学学报 (医学版), 2022, 60(9): 35-41.
[3] 彭超,周应芳. 子宫腺肌病的药物治疗进展[J]. 山东大学学报 (医学版), 2022, 60(7): 20-25.
[4] 冷金花,史精华. 子宫腺肌病的临床表现[J]. 山东大学学报 (医学版), 2022, 60(7): 1-5.
[5] 陈忠绍,褚然,李明宝,张向宁. MRKH综合征相关腹股沟子宫疝修补术后腹壁瘢痕子宫内膜异位症1例报道并文献复习[J]. 山东大学学报 (医学版), 2022, 60(5): 114-117.
[6] 林雪艳,张灿灿,田民乐,田永杰. 聚腺苷酸二磷酸核糖聚合酶-1在子宫内膜异位症中的表达及意义[J]. 山东大学学报 (医学版), 2022, 60(2): 27-31.
[7] 鞠建华,杨镇业,李青连,韩亚楠,李艳青,乔伊君,杨虎,张华然. 微生物药物研究开发现状与思考[J]. 山东大学学报 (医学版), 2021, 59(9): 43-50,63.
[8] 单婧,王晓秋,李大金. NK细胞参与子宫内膜异位症及其不孕的分子机制[J]. 山东大学学报 (医学版), 2021, 59(8): 8-13.
[9] 梁炎春,叶海花,陆丽美,戴郁菁,程谦益,蔡婉玲,曾涵秋,陈杏欢,王兴,韦雅婧,杨如玉. 慢性子宫内膜炎对子宫内膜异位症相关性不孕妊娠结局的影响[J]. 山东大学学报 (医学版), 2021, 59(3): 55-59.
[10] 薛源,林雪艳,徐歌,田永杰. 低氧诱导因子-1α在子宫内膜异位症患者血清中的表达和对在位子宫内膜间质细胞上皮-间质转化的影响[J]. 山东大学学报 (医学版), 2021, 59(2): 41-47.
[11] 潘虹江,王焕昇,裴发军,杨明山. 孤立性膀胱子宫内膜异位症1例[J]. 山东大学学报 (医学版), 2021, 59(2): 122-124.
[12] 王国云,王凯,袁明,陈子江. 子宫内膜异位症立体化管理体系(山东方案)[J]. 山东大学学报 (医学版), 2021, 59(10): 1-16.
[13] 王世宣,张金金. 卵巢衰老的机制与预防研究进展[J]. 山东大学学报 (医学版), 2019, 57(2): 16-22.
[14] 黄存瑞,何依伶,马锐,苏亚男. 高温热浪的健康效应:从影响评估到应对策略[J]. 山东大学学报 (医学版), 2018, 56(8): 14-20.
[15] 秦鲁敏,孙爱友,王倩文,高景文,魏东芝. 高残糖-pH反复重碱化震荡策略提高乳酸片球菌素产量[J]. 山东大学学报(医学版), 2017, 55(9): 41-45.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!